Acamprosate alcohol intake weaned alcoholics hundred sixty-nine alcoholics double-blind placebo-controlled multicenter study effects Acamprosate calcium acetylhomotaurinate CA g/day indicators alcoholic relapse withdrawal eighty-one patients CA group placebo group three-month study major efficacy criterion plasma gamma-glutamyl transpeptidase GGT indicator recent alcohol ingestion analysis criteria concordance analysis number indicators alcohol intake Patients groups similar months treatment patients CA group GGT versus times normal significant differences trends favor superior effect CA placebo major side-effect CA present CA patients placebo CA superior evolution markers alcohol ingestion months large-scale multicenter study new modality drug therapy alcoholism antabuse effect antidepressant action conditioning 